Elizabeth H Weatherman bought $497K of Insulet (PODD)
Executed Jun 3, disclosed Jun 3, the same day.
Over the 21 trading sessions from the disclosed entry session (Jun 3), the stock returned +13.9% (delay-adjusted); from the execution session (Jun 3), +13.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
Elizabeth H Weatherman (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Insulet Corporation (PODD). Across 1 priced purchase filing, the average 21-session return was +13.9% from execution and +13.9% from disclosure (delay-adjusted; derived). The largest single filing was $497K of PODD (3,450 sh × $144.20, as filed), executed Jun 3.
Healthcare · Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United Sta…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→